Physician profile
John P Donovan
NPI 1508821844
$1,530.58
in general payments reported to CMS, 2019-2025
17 companies · $13.96 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $443 · 2020: $186 · 2021: $395 · 2022: $154 · 2023: $41.74 · 2024: $296 · 2025: $13.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $352.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $497.03 | 2019-2024 | Rocklatan |
| Horizon Therapeutics Plc | $133.65 | 2022-2023 | Tepezza |
| Allergan, INC. | $128.51 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $121.85 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $111.48 | 2024 | Miebo, Xiidra |
| Aerie Pharmaceuticals, INC. | $108.85 | 2021 | |
| Merck Sharp & Dohme LLC | $105.15 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $74.71 | 2019-2022 | |
| Johnson & Johnson Vision Care, INC. | $73.13 | 2020-2021 | |
| Tarsus Pharmaceuticals, INC. | $40.86 | 2024-2025 | Xdemvy |
| Regeneron Healthcare Solutions, INC. | $24.59 | 2020-2021 | |
| Biogen, INC. | $19.92 | 2024 | Byooviz |
| Shire North American Group INC | $19.80 | 2019 | |
| Omeros Corporation | $19.68 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $19.06 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $17.29 | 2024 | |
| Astellas Pharma US INC | $15.02 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Donovan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.